HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiarrhythmic properties of antidepressant drugs after coronary artery occlusion and reperfusion in rats.

Abstract
The effects of the intravenously administered antidepressant drugs mianserin, imipramine, metapramine, nomifensine and amineptine against ischaemia and reperfusion arrhythmias were investigated in anaesthetized rats. Imipramine, metapramine, mianserin and high doses of nomifensine (0.5 mg.kg-1) reduced the mortality and the duration of ventricular fibrillation observed following coronary artery ligation. Amineptine was ineffective in preventing early postligation arrhythmias. With the tricyclic antidepressant drugs imipramine and metapramine, the arrhythmias were practically suppressed after 15 min following coronary artery ligation. The incidence of reperfusion arrhythmias was significantly reduced by tricyclic antidepressant drugs. In contrast, amineptine was not effective and did not alter cardiac function. It was suggested that nonspecific effects of these drugs account for their antiarrhythmic action. The most plausible explanation for their antiarrhythmic action may be a quinidine-like cardiac depressant activity.
AuthorsA Bril, L Rochette
JournalPharmacology (Pharmacology) Vol. 36 Issue 1 Pg. 16-26 ( 1988) ISSN: 0031-7012 [Print] Switzerland
PMID3340651 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Arrhythmia Agents
  • Antidepressive Agents
  • Antidepressive Agents, Tricyclic
Topics
  • Animals
  • Anti-Arrhythmia Agents
  • Antidepressive Agents (pharmacology)
  • Antidepressive Agents, Tricyclic (pharmacology)
  • Arrhythmias, Cardiac (etiology, prevention & control)
  • Blood Pressure (drug effects)
  • Coronary Disease (complications, drug therapy)
  • Heart Rate (drug effects)
  • Male
  • Rats
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: